EPHA2 and renal cell carcinoma: In a small cohort of 34 RCC, which also included four non-ccRCCs, Herrem et al. demonstrated that EPHA2 protein expression is elevated in high-grade tumors and correlated inversely with progression-free interval and overall survival period [22].